Indian Immunologicals inks MoU with Argentina firm for bovine vaccines

Hyderabad, June 12 (IANS) Indian Immunologicals Limited (IIL), the largest animal vaccine manufacturer in Asia, has signed a MoU with INTA and Littoral Biologics of Argentina for transfer of technology to produce bovine parasitic vaccines in India.

Introduction of vaccines against haemoprotozoan infections transmitted by ticks such as Babesiosis and Anaplasmosis will prevent loss in productivity in cattle and immensely benefit dairy farmers, said a statement by IIL.

IIL is a wholly owned subsidiary of the National Dairy Development Board (NDDB).

Instituto Nacional de Tecnologia Agropecuaria (INTA), Argentina is Argentinian federal agency in charge of the generation, adaptation and diffusion of technologies.

Manual G. Garcia, Director General of Littoral, Nicora Amadeo, President INTA, Cerioni Adolfo Luis, National Coordinator, INTA, Argentina signed the agreement with Indian Immunologicals to transfer technology to produce vaccine against Babesiosis and Anaplasmosis.

"Economic losses due to Babesisosis alone in India are estimated to be about $57.2 million", said K. Anand Kumar, Managing Director, IIL.

"IIL is only vaccine manufacturer in India which is capable of producing effective parasitic vaccines for animals with vast experience in producing vaccine against haemoprotozoan Theileria annulata, since three decades. IIL recently introduced vaccine against Porcine Cysticercosis, a parasitic vaccine for Pigs. This agreement with the Argentinean collaborators will go a long way in uplifting productivity among dairy farmers in India," he added.

IIL's Rakshavac-T (Vaccine against Theileria annulata) is the only vaccine against haemoprotozoan infections in India.

(This story has not been edited by Social News XYZ staff and is auto-generated from a syndicated feed.)